|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02269 WUXI BIO
Nominal 
50.650 +0.150 (+0.297%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 6,340,922 | 5,217,257 | 4,667,712 | 5,541,673 |
| Net Cash from / (used in) Investing Activities | -- | (3,087,142) | (3,941,706) | (3,228,266) | (5,908,252) |
| Net Cash from / (used in) Financing Activities | -- | (2,163,968) | (2,750,191) | 1,961,163 | (2,591,592) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 1,089,812 | (1,474,640) | 3,400,609 | (2,958,171) |
| Cash & Cash Equivalents at beginning of period | -- | 8,279,182 | 9,669,839 | 6,395,222 | 9,003,280 |
| Effect of Foreign Exchange Rate Changes | -- | (155,208) | 83,983 | (125,992) | 350,113 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 9,213,786 | 8,279,182 | 9,669,839 | 6,395,222 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,439,813 |
| %Change | 4.298% |
| EPS / (LPS) | RMB 0.600 |
| NBV Per Share (¥) | RMB 11.602 |